• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Vanderbilt Medical Center

Study: Protein ferries molecule to tumors, triggering self-destruction

July 25, 2017 By Sarah Faulkner

Ribonucleic acids, which can alter the behavior of cancerous cells, can be effectively ferried to tumors using a human protein called albumin, according to research conducted by a team of engineers at Vanderbilt University. The team’s work could help boost treatment for patients with triple-negative breast cancer, the researchers reported in the journal Proceedings of the National […]

Filed Under: Drug-Device Combinations, Oncology, Pharmaceutical, Research & Development Tagged With: Vanderbilt Medical Center, vanderbiltuniversity

Video: Vandy researchers develop needle-sized endoscopic ‘wrist’

July 27, 2015 By Fink Densford

  Researchers at Vanderbilt University announced last week that they developed a surgical robot with steerable needle equipped with wrists smaller than 2 mm thick for use during micro-laproscopic, or needlescopic, surgeries. The device is designed to provide greater dexterity to the microscopic tools, something they currently lack. The new wrists would allow surgeon-operators to perform […]

Filed Under: Clinical Trials, Emerging Markets, Research & Development, Robotics Tagged With: Vanderbilt Medical Center

Bypass beats stenting for diabetics | MassDevice.com On Call

September 16, 2013 By Brad Perriello Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — The risk of death was reduced by a third in patients with diabetes who underwent coronary artery bypass graft surgery, compared with percutaneous coronary intervention with stents, according to new study results.

Researchers examined data from 4 clinical trials comparing CABG with PCI using bare-metal stents in diabetics with multi-vessel heart disease and another 4 trials that compared CABG with drug-eluting stent PCIs.

Filed Under: News Well, Stents Tagged With: On Call, Vanderbilt Medical Center

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS